1. Efficacy of psychotropic drugs in functional dyspepsia: systematic review and meta-analysis.
作者: Alexander C Ford.;Pavit Luthra.;Jan Tack.;Guy E Boeckxstaens.;Paul Moayyedi.;Nicholas J Talley.
来源: Gut. 2017年66卷3期411-420页
Functional dyspepsia (FD) is a chronic gastroduodenal disorder. Individuals with FD demonstrate visceral hypersensitivity, abnormal central pain processing, and low mood, but it is unclear whether psychotropic drugs are an effective treatment for the condition. We performed a systematic review and meta-analysis of randomised controlled trials (RCTs).
2. Dual role of Helicobacter and Campylobacter species in IBD: a systematic review and meta-analysis.
作者: Natalia Castaño-Rodríguez.;Nadeem O Kaakoush.;Way Seah Lee.;Hazel M Mitchell.
来源: Gut. 2017年66卷2期235-249页
To conduct a comprehensive global systematic review and meta-analysis on the association between Helicobacter pylori infection and IBD. As bacterial antigen cross-reactivity has been postulated to be involved in this association, published data on enterohepatic Helicobacter spp (EHS) and Campylobacter spp and IBD was also analysed.
3. Biomarkers for bile acid diarrhoea in functional bowel disorder with diarrhoea: a systematic review and meta-analysis.
作者: Nelson Valentin.;Michael Camilleri.;Osama Altayar.;Priya Vijayvargiya.;Andres Acosta.;Alfred D Nelson.;M Hassan Murad.
来源: Gut. 2016年65卷12期1951-1959页
There is no universally available laboratory test to diagnose bile acid diarrhoea (BAD).
4. Genetic variation and gastric cancer risk: a field synopsis and meta-analysis.
Data on genetic susceptibility to sporadic gastric carcinoma have been published at a growing pace, but to date no comprehensive overview and quantitative summary has been available.
5. Efficacy and safety of endoscopic resection of large colorectal polyps: a systematic review and meta-analysis.
作者: C Hassan.;A Repici.;P Sharma.;L Correale.;A Zullo.;M Bretthauer.;C Senore.;C Spada.;Cristina Bellisario.;P Bhandari.;D K Rex.
来源: Gut. 2016年65卷5期806-20页
To assess the efficacy and safety of endoscopic resection of large colorectal polyps.
6. Training and competence assessment in GI endoscopy: a systematic review.
作者: Vivian E Ekkelenkamp.;Arjun D Koch.;Robert A de Man.;Ernst J Kuipers.
来源: Gut. 2016年65卷4期607-15页
Training procedural skills in GI endoscopy once focused on threshold numbers. As threshold numbers poorly reflect individual competence, the focus gradually shifts towards a more individual approach. Tools to assess and document individual learning progress are being developed and incorporated in dedicated training curricula. However, there is a lack of consensus and training guidelines differ worldwide, which reflects uncertainties on optimal set-up of a training programme.
7. Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis.
Many cross-sectional surveys have reported the prevalence of uninvestigated dyspepsia, but there has been no recent systematic review of data from all studies to determine its global prevalence and risk factors.
8. Systematic review: Monotherapy with antitumour necrosis factor α agents versus combination therapy with an immunosuppressive for IBD.
作者: Parambir S Dulai.;Corey A Siegel.;Jean-Frederic Colombel.;William J Sandborn.;Laurent Peyrin-Biroulet.
来源: Gut. 2014年63卷12期1843-53页 9. A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn's disease.
作者: Krisztina B Gecse.;Willem Bemelman.;Michael A Kamm.;Jaap Stoker.;Reena Khanna.;Siew C Ng.;Julián Panés.;Gert van Assche.;Zhanju Liu.;Ailsa Hart.;Barrett G Levesque.;Geert D'Haens.; .; .
来源: Gut. 2014年63卷9期1381-92页
To develop a consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn's disease (pCD), based on best available evidence.
10. Hospital and surgeon volume in relation to long-term survival after oesophagectomy: systematic review and meta-analysis.
Centralisation of healthcare, especially for advanced cancer surgery, has been a matter of debate. Clear short-term mortality benefits have been described for oesophageal cancer surgery conducted at high-volume hospitals and by high-volume surgeons.
11. Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysis.
作者: Siddharth Singh.;Sushil Kumar Garg.;Preet Paul Singh.;Prasad G Iyer.;Hashem B El-Serag.
来源: Gut. 2014年63卷8期1229-37页
Acid-suppressive medications, particularly proton pump inhibitors (PPIs), may decrease the risk of oesophageal adenocarcinoma (OAC) in patients with Barrett's oesophagus (BO). We performed a systematic review with meta-analysis of studies evaluating the association between acid-suppressive medications (PPIs and histamine receptor antagonists (H2RAs)) and risk of OAC or high-grade dysplasia (BO-HGD) in patients with BO.
12. The burden of stomach cancer in indigenous populations: a systematic review and global assessment.
作者: Melina Arnold.;Suzanne P Moore.;Sven Hassler.;Lis Ellison-Loschmann.;David Forman.;Freddie Bray.
来源: Gut. 2014年63卷1期64-71页
Stomach cancer is a leading cause of cancer death, especially in developing countries. Incidence has been associated with poverty and is also reported to disproportionately affect indigenous peoples, many of whom live in poor socioeconomic circumstances and experience lower standards of health. In this comprehensive assessment, we explore the burden of stomach cancer among indigenous peoples globally.
13. Newly diagnosed diabetes mellitus after acute pancreatitis: a systematic review and meta-analysis.
作者: Stephanie L M Das.;Primal P Singh.;Anthony R J Phillips.;Rinki Murphy.;John A Windsor.;Maxim S Petrov.
来源: Gut. 2014年63卷5期818-31页
Diabetes mellitus (DM) is common in the general population and it poses a heavy burden to society in the form of long-term disability, healthcare use and costs. The pancreas is a key player in glucose homeostasis, but the occurrence of newly diagnosed DM after acute pancreatitis (AP), the most frequent disease of the pancreas, has never been assessed systematically. The aim of this study was to conduct a systematic literature review to determine the prevalence and time course of DM and related conditions after the first attack of AP as well as the impact of covariates.
14. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review.
作者: Hashem B El-Serag.;Stephen Sweet.;Christopher C Winchester.;John Dent.
来源: Gut. 2014年63卷6期871-80页
To update the findings of the 2005 systematic review of population-based studies assessing the epidemiology of gastro-oesophageal reflux disease (GERD).
15. Crohn's disease complicated by strictures: a systematic review.
作者: Florian Rieder.;Ellen M Zimmermann.;Feza H Remzi.;William J Sandborn.
来源: Gut. 2013年62卷7期1072-84页
The occurrence of strictures as a complication of Crohn's disease is a significant clinical problem. No specific antifibrotic therapies are available. This systematic review comprehensively addresses the pathogenesis, epidemiology, prediction, diagnosis and therapy of this disease complication. We also provide specific recommendations for clinical practice and summarise areas that require future investigation.
16. Narrow band imaging to differentiate neoplastic and non-neoplastic colorectal polyps in real time: a meta-analysis of diagnostic operating characteristics.
作者: Sarah K McGill.;Evangelos Evangelou.;John P A Ioannidis.;Roy M Soetikno.;Tonya Kaltenbach.
来源: Gut. 2013年62卷12期1704-13页
Many studies have reported on the use of narrow band imaging (NBI) colonoscopy to differentiate neoplastic from non-neoplastic colorectal polyps. It has potential to replace pathological diagnosis of diminutive polyps. We aimed to perform a systematic review and meta-analysis on the real-time diagnostic operating characteristics of NBI colonoscopy.
17. Mucosal healing in inflammatory bowel diseases: a systematic review.
Recent studies have identified mucosal healing on endoscopy as a key prognostic parameter in the management of inflammatory bowel diseases (IBD), thus highlighting the role of endoscopy for monitoring of disease activity in IBD. In fact, mucosal healing has emerged as a key treatment goal in IBD that predicts sustained clinical remission and resection-free survival of patients. The structural basis of mucosal healing is an intact barrier function of the gut epithelium that prevents translocation of commensal bacteria into the mucosa and submucosa with subsequent immune cell activation. Thus, mucosal healing should be considered as an initial event in the suppression of inflammation of deeper layers of the bowel wall, rather than as a sign of complete healing of gut inflammation. In this systematic review, the clinical studies on mucosal healing are summarised and the effects of anti-inflammatory or immunosuppressive drugs such as 5-aminosalicylates, corticosteroids, azathioprine, ciclosporin and anti-TNF antibodies (adalimumab, certolizumab pegol, infliximab) on mucosal healing are discussed. Finally, the implications of mucosal healing for subsequent clinical management in patients with IBD are highlighted.
18. Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health.
作者: Laurent Peyrin-Biroulet.;Alarcos Cieza.;William J Sandborn.;Michaela Coenen.;Yehuda Chowers.;Toshifumi Hibi.;Nenad Kostanjsek.;Gerold Stucki.;Jean-Frédéric Colombel.; .
来源: Gut. 2012年61卷2期241-7页
The impact of inflammatory bowel disease (IBD) on disability remains poorly understood. The World Health Organization's integrative model of human functioning and disability in the International Classification of Functioning, Disability and Health (ICF) makes disability assessment possible. The ICF is a hierarchical coding system with four levels of details that includes over 1400 categories. The aim of this study was to develop the first disability index for IBD by selecting most relevant ICF categories that are affected by IBD.
19. Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysis.
There has been no definitive systematic review and meta-analysis to date examining the effect of laxatives and pharmacological therapies in chronic idiopathic constipation (CIC).
20. Peutz-Jeghers syndrome: a systematic review and recommendations for management.
作者: A D Beggs.;A R Latchford.;H F A Vasen.;G Moslein.;A Alonso.;S Aretz.;L Bertario.;I Blanco.;S Bülow.;J Burn.;G Capella.;C Colas.;W Friedl.;P Møller.;F J Hes.;H Järvinen.;J-P Mecklin.;F M Nagengast.;Y Parc.;R K S Phillips.;W Hyer.;M Ponz de Leon.;L Renkonen-Sinisalo.;J R Sampson.;A Stormorken.;S Tejpar.;H J W Thomas.;J T Wijnen.;S K Clark.;S V Hodgson.
来源: Gut. 2010年59卷7期975-86页
Peutz-Jeghers syndrome (PJS, MIM175200) is an autosomal dominant condition defined by the development of characteristic polyps throughout the gastrointestinal tract and mucocutaneous pigmentation. The majority of patients that meet the clinical diagnostic criteria have a causative mutation in the STK11 gene, which is located at 19p13.3. The cancer risks in this condition are substantial, particularly for breast and gastrointestinal cancer, although ascertainment and publication bias may have led to overestimates in some publications. Current surveillance protocols are controversial and not evidence-based, due to the relative rarity of the condition. Initially, endoscopies are more likely to be done to detect polyps that may be a risk for future intussusception or obstruction rather than cancers, but surveillance for the various cancers for which these patients are susceptible is an important part of their later management. This review assesses the current literature on the clinical features and management of the condition, genotype-phenotype studies, and suggested guidelines for surveillance and management of individuals with PJS. The proposed guidelines contained in this article have been produced as a consensus statement on behalf of a group of European experts who met in Mallorca in 2007 and who have produced guidelines on the clinical management of Lynch syndrome and familial adenomatous polyposis.
|